LyondellBasell Industries N.V. LYB

Healthcare SIC 2860 - Industrial Organic Chemicals NAICS Manufacturing › Chemical Manufacturing › Basic Chemical Manufacturing › Other Basic Organic Chemical Manufacturing derived NYSE

and 2. Business and Properties.

LyondellBasell Industries N.V. is a global, independent chemical company and was incorporated, as a Naamloze Vennootschap, under Dutch law on October 15, 2009. Unless otherwise indicated, the "Company," "we," "our," "us" and "LyondellBasell" are used in this report to refer to the businesses of LyondellBasell Industries N.V. and its consolidated subsidiaries.

We participate globally across the petrochemical value chain and are an industry leader in many of our product lines. Our chemicals businesses consist primarily of large processing plants that convert large volumes of liquid and gaseous hydrocarbon feedstocks into plastic resins and other chemicals. Our chemical products tend to be basic building blocks for other chemicals and plastics. Our plastic products are used in large volumes as well as smaller specialty applications. Our customers use our plastics and chemicals to manufacture a wide range of products that people use in their everyday lives, including food packaging, home furnishings, automotive components, paints and coatings. We also develop and license chemical and polyolefin process technologies, and manufacture and sell polyolefin catalysts.

Last close 66.45 2026-10-23
Market cap $21.47B 2026-06-30 share count
52-week range 41.58 - 83.94

Valuation FY2025 figures against the last close

P/S0.7x
P/E—
P/FCF55.9x
EV/EBITDA16.7x
Dividend yield8.2%
Diluted EPS-2.34

Where the revenue comes from as reported in the latest 10-K

Revenue by geography

  • United States
  • Other
  • Germany
  • China
  • Mexico
  • Italy
  • Japan
  • France
  • Poland
  • The Netherlands
Revenue by geography, 10 categories over 3 years. The same figures are in the table below. FY2025 United States, FY2025: 11.1B (36.7%) 37% United States Other, FY2025: 8.3B (27.5%) 27% Other Germany, FY2025: 2.2B (7.3%) 7% Germany China, FY2025: 1.8B (5.9%) 6% China Mexico, FY2025: 1.6B (5.2%) 5% Mexico Italy, FY2025: 1.3B (4.4%) 4% Italy Japan, FY2025: 1.3B (4.2%) 4% Japan France, FY2025: 1.2B (3.9%) 4% Poland, FY2025: 790M (2.6%) The Netherlands, FY2025: 731M (2.4%) FY2024 United States, FY2024: 12.6B (37.7%) 38% Other, FY2024: 8.8B (26.4%) 26% Germany, FY2024: 2.4B (7.2%) 7% China, FY2024: 2.4B (7.1%) 7% Mexico, FY2024: 1.7B (5.2%) 5% Italy, FY2024: 1.4B (4.2%) 4% Japan, FY2024: 1.3B (4.0%) 4% France, FY2024: 1.1B (3.2%) Poland, FY2024: 923M (2.8%) The Netherlands, FY2024: 724M (2.2%) FY2023 United States, FY2023: 12.4B (37.2%) 37% Other, FY2023: 8.8B (26.5%) 26% Germany, FY2023: 2.5B (7.6%) 8% China, FY2023: 2.2B (6.5%) 6% Mexico, FY2023: 1.5B (4.5%) 4% Italy, FY2023: 1.4B (4.1%) 4% Japan, FY2023: 1.7B (5.2%) 5% France, FY2023: 1.1B (3.3%) Poland, FY2023: 905M (2.7%) The Netherlands, FY2023: 805M (2.4%)
Region FY2025FY2024FY2023
United States $11.06B $12.59B $12.39B
Other $8.29B $8.82B $8.82B
Germany $2.20B $2.41B $2.55B
China $1.78B $2.38B $2.16B
Mexico $1.56B $1.73B $1.50B
Italy $1.32B $1.42B $1.36B
Japan $1.26B $1.34B $1.75B
France $1.16B $1.07B $1.09B
Poland $790.0M $923.0M $905.0M
The Netherlands $731.0M $724.0M $805.0M

As the company reported it, from the “Revenues - Geographic location (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $30.15B$33.39B$33.34B$50.45B$46.17B$27.00B$33.91B$38.13B$33.70B$28.45B
Cost of revenue $27.58B$28.75B$28.43B$43.85B$37.40B$24.36B$29.30B$32.53B$28.06B$23.19B
Gross profit $2.58B$4.64B$4.90B$6.60B$8.78B$2.64B$4.61B$5.60B$5.65B$5.26B
R&D $136.0M$135.0M$130.0M$124.0M$124.0M$113.0M$111.0M$115.0M$106.0M$99.0M
SG&A $1.61B$1.64B$1.54B$1.31B$1.25B$1.14B$1.20B$1.13B$859.0M$833.0M
Total operating expenses $30.57B$31.48B$30.61B$45.35B$39.40B$26.19B$30.61B$33.77B$29.02B$24.12B
Operating income -$420.0M$1.92B$2.73B$5.10B$6.77B$1.56B$4.12B$5.23B$5.46B$5.06B
Interest expense $487.0M$481.0M$477.0M$287.0M$519.0M$526.0M$347.0M$360.0M$491.0M$322.0M
Pre-tax income -$715.0M$1.70B$2.30B$4.78B$6.79B$1.39B$4.05B$5.31B$5.49B$5.23B
Income tax $70.0M$259.0M$433.0M$882.0M$1.16B$43.0M$648.0M$613.0M$598.0M$1.39B
Net income -$738.0M$1.37B$2.12B$3.89B$5.62B$1.43B$3.40B$4.69B$4.88B$3.84B
EPS, basic -2.344.166.4811.8416.774.249.5912.0412.239.15
EPS, diluted -2.344.156.4611.8116.754.249.5812.0112.239.13

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $3.44B$3.38B$3.40B$2.16B$1.48B$1.76B$888.0M$401.0M$1.53B$878.0M
Short-term investments $2.03B$2.61B$2.43B$1.19B$9.0M$702.0M$196.0M$892.0M$1.31B$1.15B
Receivables ———$3.39B$4.57B$3.29B$2.98B$3.35B$3.36B$2.72B
Inventory $3.53B$4.66B$4.76B$4.80B$4.90B$4.34B$4.59B$4.51B$4.22B$3.81B
Total current assets $10.87B$12.27B$13.15B$11.85B$12.22B$11.63B$9.51B$10.57B$11.74B$9.60B
Property, plant and equipment $15.83B$15.07B$15.55B$15.39B$14.56B$14.39B$14.13B$12.48B$11.00B$10.14B
Goodwill $708.0M$1.56B$1.65B$1.83B$1.88B$1.95B$1.89B$1.81B$570.0M$528.0M
Other intangibles $450.0M$577.0M$641.0M$662.0M$695.0M$751.0M$869.0M$965.0M$568.0M$550.0M
Total assets $34.00B$35.75B$37.00B$36.37B$36.74B$35.40B$30.43B$28.28B$26.21B$23.44B
Short-term debt $226.0M$119.0M$117.0M$349.0M$362.0M$663.0M$445.0M$885.0M$68.0M$594.0M
Total current liabilities $6.13B$6.71B$7.15B$6.76B$7.23B$5.50B$5.20B$5.51B$4.78B$4.54B
Retained earnings $6.81B$9.32B$9.69B$9.20B$8.56B$4.44B$4.43B$6.76B$15.75B$12.28B
Total equity $10.08B$12.46B$12.93B$12.62B$11.86B$7.97B$8.04B$10.26B$8.95B$6.05B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $2.26B$3.82B$4.94B$6.12B$7.70B$3.40B$4.96B$5.47B$5.21B$5.61B
Depreciation and amortisation $1.39B$1.52B$1.53B$1.27B$1.39B$1.39B$1.31B$1.24B$1.17B$1.06B
Stock-based compensation $91.0M$91.0M$91.0M$70.0M$66.0M$55.0M$48.0M$39.0M$55.0M$38.0M
Capital expenditure $1.88B$1.84B$1.53B$1.89B$1.96B$1.95B$2.69B$2.10B$1.55B$2.24B
Investing cash flow -$1.78B-$1.85B-$1.78B-$1.98B-$1.50B-$4.91B-$1.64B-$3.56B-$1.76B-$2.30B
Financing cash flow -$507.0M-$1.90B-$1.95B-$3.41B-$6.38B$2.27B-$2.83B-$3.01B-$2.86B-$3.35B
Dividends paid $1.76B$1.72B$1.61B$3.25B$1.49B$1.41B$1.46B$1.55B$1.42B$1.40B
Buybacks $201.0M$195.0M$211.0M$420.0M$463.0M$4.0M$3.75B$1.85B$866.0M$2.94B

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001308179-26-000250.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -20B 0 20B 40B 60B Revenue, FY2016: 28.5B Gross profit, FY2016: 5.3B Net income, FY2016: 3.8B Revenue, FY2017: 33.7B Gross profit, FY2017: 5.6B Net income, FY2017: 4.9B Revenue, FY2018: 38.1B Gross profit, FY2018: 5.6B Net income, FY2018: 4.7B Revenue, FY2019: 33.9B Gross profit, FY2019: 4.6B Net income, FY2019: 3.4B Revenue, FY2020: 27B Gross profit, FY2020: 2.6B Net income, FY2020: 1.4B Revenue, FY2021: 46.2B Gross profit, FY2021: 8.8B Net income, FY2021: 5.6B Revenue, FY2022: 50.5B Gross profit, FY2022: 6.6B Net income, FY2022: 3.9B Revenue, FY2023: 33.3B Gross profit, FY2023: 4.9B Net income, FY2023: 2.1B Revenue, FY2024: 33.4B Gross profit, FY2024: 4.6B Net income, FY2024: 1.4B Revenue, FY2025: 30.2B Gross profit, FY2025: 2.6B Net income, FY2025: -738M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $28.45B $33.70B $38.13B $33.91B $27.00B $46.17B $50.45B $33.34B $33.39B $30.15B
Gross profit $5.26B $5.65B $5.60B $4.61B $2.64B $8.78B $6.60B $4.90B $4.64B $2.58B
Net income $3.84B $4.88B $4.69B $3.40B $1.43B $5.62B $3.89B $2.12B $1.37B -$738.0M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Results announced Item 2.02
  • Other event Item 8.01
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Material agreement signed Item 1.01
  • New debt or obligation Item 2.03

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2860

TickerCompanyMarket capP/ERevenue growth
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC $24.02B — -5.2%
WLK WESTLAKE CORP $8.25B — -8.0%
NEU NEWMARKET CORP $8.01B 19.6x -2.2%
SXT SENSIENT TECHNOLOGIES CORP $5.65B 42.0x 3.5%
REX REX AMERICAN RESOURCES Corp $1.32B 15.9x 1.2%
GPRE Green Plains Inc. $979.9M — 16.0%
WLKP Westlake Chemical Partners LP $745.5M — 2.7%
GEVO Gevo, Inc. $286.8M — 849.3%